The website of the Clinical Services Journal

Dräger acquires majority share of Swiss start-up Stimit

Drägerwerk AG & Co. KGaA has acquired the majority share of Stimit AG. With this acquisition, Dräger further expands its expertise in the field of lung-protective ventilation.

Different courses of disease may require artificial respiration. The novel coronavirus is just one of them. If the body is no longer able to breathe on its own to a sufficient extent, mechanical ventilation can save lives. However, after just a few days of ventilation, there is a risk of weakening the respiratory muscles and diaphragm. In order for patients to be able to breathe on their own again, the diaphragm, as the most important respiratory muscle, must be maintained and built up. Stimit plans to achieve this by means of electromagnetic fields that stimulate the diaphragm.

"Stimit is working on a solution that is not yet available on the market. By acquiring a majority stake, we secure a head start in the development of non-invasive stimulation of respiratory muscles," said Stephan Kruse, Head of Business Unit, Therapy, at Dräger. "As an expert in ventilation technology, we are interested in making ventilation as gentle as possible and to drive forward innovative solutions in this field."

Stimit will work together with Dräger in the following months to further develop the product and conduct clinical trials.

The Swiss-based start-up was founded in 2018 and works on solutions to strengthen the respiratory muscles of artificially ventilated intensive care patients, in a non-invasive way. Among other things, it aims to positively influence the weaning process from ventilation. Currently, the duration of the weaning process from artificial ventilation in ICU patients is approximately between 40 and 50 percent of the total ventilation time. The weaning process usually becomes more difficult as the duration of ventilation increases. In the long term, electromagnetic stimulation of the diaphragm should help shorten the period of ventilation and thus the time of hospitalisation, as well as reduce the risk of complications.

 

 

Upcoming Events

Central Sterilising Club - Annual Scientific Meeting 2024

Crowne Plaza at Gerrard’s Cross
15th April 2024 – 16th April 2024

DECON UK 2024

National Conference Centre, Birmingham
17th April 2024

Infection Prevention & Control

National Conference Centre, Birmingham
23rd - 24th April 2024

Theatres & Decontamination Conference 2024

Coventry Building Society Arena
16th May 2024

The AfPP Roadshow - Birmingham

Millennium Point, Birmingham
18th May 2024

The AfPP Roadshow - Exeter

University of Exeter
22nd June 2024

Access the latest issue of Clinical Services Journal on your mobile device together with an archive of back issues.

Download the FREE Clinical Services Journal app from your device's App store

Upcoming Events

Central Sterilising Club - Annual Scientific Meeting 2024

Crowne Plaza at Gerrard’s Cross
15th April 2024 – 16th April 2024

DECON UK 2024

National Conference Centre, Birmingham
17th April 2024

Infection Prevention & Control

National Conference Centre, Birmingham
23rd - 24th April 2024

Theatres & Decontamination Conference 2024

Coventry Building Society Arena
16th May 2024

The AfPP Roadshow - Birmingham

Millennium Point, Birmingham
18th May 2024

The AfPP Roadshow - Exeter

University of Exeter
22nd June 2024

Access the latest issue of Clinical Services Journal on your mobile device together with an archive of back issues.

Download the FREE Clinical Services Journal app from your device's App store

Step Communications Ltd, Step House, North Farm Road, Tunbridge Wells, Kent TN2 3DR
Tel: 01892 779999
www.step-communications.com
© 2024 Step Communications Ltd. Registered in England. Registration Number 3893025